Why is Hemo Organic falling/rising?

As of 08-Jul, Hemo Organic Ltd's stock price is currently at 9.61, reflecting a slight increase of 0.01 (0.1%). The stock has recently shown a trend reversal, gaining after six consecutive days of decline. However, it is still trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally weak performance. The stock has underperformed significantly over various periods, with a 1-week return of -10.10% and a year-to-date return of -22.87%. Despite some positive quarterly results, including the highest PBDIT and PAT figures, the company faces challenges such as a negative book value, high debt levels, and a negative EBITDA, contributing to its weak long-term fundamental strength.
In the broader market context, Hemo Organic's recent performance contrasts sharply with the benchmark, as it has consistently underperformed against the BSE500 over the last three years. While the Sensex has shown a slight increase of 0.02% over the past week, Hemo Organic's substantial decline highlights its struggles in attracting investor participation, evidenced by a 43.45% drop in delivery volume compared to the 5-day average. This combination of poor stock performance, high debt, and negative growth prospects suggests a challenging environment for Hemo Organic, further exacerbated by its inability to keep pace with the broader market trends.